1. Prevalence of cardiac amyloidosis in patients with unexplained left ventricle hypertrophy. (14th October 2021) Authors: Holcman, K; Kostkiewicz, M; Szot, W; Lesniak-Sobelga, A; Hlawaty, M; Wisniowska-Smialek, S; Dziewiecka, E; Karabinowska, A; Stepien, A; Graczyk, K; Mroz, K; Podolec, P; Rubis, P Journal: European heart journal Issue: Volume 42(2021)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Scintigraphic and echocardiographic evaluation of patients with cardiac transthyretin amyloidosis and first-degree relatives. (20th July 2021) Authors: Holcman, K; Rubis, P; Szot, W; Graczyk, K; Stepien, A; Lesniak-Sobelga, A; Hlawaty, M; Wisniowska-Smialek, S; Dziewiecka, E; Karabinowska, A; Mroz, K; Podolec, P; Kostkiewicz, M Journal: European heart journal Issue: Volume 22(2021)Supplement 3 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗